Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Vagner

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 23, 2010
Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptorsLiping Xu, Josef Vagner, Ramesh Alleti, et al.
Angewandte Chemie (International Ed. in English)|January 22, 2008
Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptorsJosef Vagner, Liping Xu, Heather L Handl, et al.
Organic Letters|May 19, 2009
Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imagingJatinder S Josan, David L Morse, Liping Xu, et al.
Molecular Imaging|April 4, 2008
Gold nanorods targeted to delta opioid receptor: plasmon-resonant contrast and photothermal agentsKvar C Black, Nathaniel D Kirkpatrick, Timothy S Troutman, et al.
Bioconjugate Chemistry|June 7, 2011
Cell-specific targeting by heterobivalent ligandsJatinder S Josan, Heather L Handl, Rajesh Sankaranarayanan, et al.
Chembiochem : a European Journal of Chemical Biology|November 22, 2013
Hetero-bivalent GLP-1/glibenclamide for targeting pancreatic β-cellsNathaniel J Hart, Woo Jin Chung, Craig Weber, et al.
Plos One|June 14, 2014
Development and evaluation of small peptidomimetic ligands to protease-activated receptor-2 (PAR2) through the use of lipid tetheringScott Boitano, Justin Hoffman, Dipti V Tillu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Heterobivalent ligands target cell-surface receptor combinations in vivoLiping Xu, Jatinder S Josan, Josef Vagner, et al.
Pain|March 4, 2015
Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain stateDipti V Tillu, Shayne N Hassler, Carolina C Burgos-Vega, et al.
The Journal of Organic Chemistry|February 7, 2007
Design, synthesis, and validation of a branched flexible linker for bioactive peptidesMartina E Bowen, Yasunari Monguchi, Rajesh Sankaranarayanan, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|March 23, 2010
Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptorsLiping Xu, Josef Vagner, Ramesh Alleti, et al.
Angewandte Chemie (International Ed. in English)|January 22, 2008
Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptorsJosef Vagner, Liping Xu, Heather L Handl, et al.
Organic Letters|May 19, 2009
Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imagingJatinder S Josan, David L Morse, Liping Xu, et al.
Molecular Imaging|April 4, 2008
Gold nanorods targeted to delta opioid receptor: plasmon-resonant contrast and photothermal agentsKvar C Black, Nathaniel D Kirkpatrick, Timothy S Troutman, et al.
Bioconjugate Chemistry|June 7, 2011
Cell-specific targeting by heterobivalent ligandsJatinder S Josan, Heather L Handl, Rajesh Sankaranarayanan, et al.
Chembiochem : a European Journal of Chemical Biology|November 22, 2013
Hetero-bivalent GLP-1/glibenclamide for targeting pancreatic β-cellsNathaniel J Hart, Woo Jin Chung, Craig Weber, et al.
Plos One|June 14, 2014
Development and evaluation of small peptidomimetic ligands to protease-activated receptor-2 (PAR2) through the use of lipid tetheringScott Boitano, Justin Hoffman, Dipti V Tillu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Heterobivalent ligands target cell-surface receptor combinations in vivoLiping Xu, Jatinder S Josan, Josef Vagner, et al.
Pain|March 4, 2015
Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain stateDipti V Tillu, Shayne N Hassler, Carolina C Burgos-Vega, et al.
The Journal of Organic Chemistry|February 7, 2007
Design, synthesis, and validation of a branched flexible linker for bioactive peptidesMartina E Bowen, Yasunari Monguchi, Rajesh Sankaranarayanan, et al.
Pageof 8